Literature DB >> 18778047

Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity.

Smritilekha Bera1, George G Zhanel, Frank Schweizer.   

Abstract

Aminoglycoside antibiotics and cationic detergents constitute two classes of clinically important drugs and antiseptics. Their bacteriological and clinical efficacy, however, has decreased recently due to antibiotic resistance. We have synthesized aminoglycoside-lipid conjugates in which the aminoglycoside neomycin forms the cationic headgroup of a polycationic detergent. Our results show that neomycin-C16 and neomycin-C20 conjugates exhibit strong Gram-positive activity but reduced Gram-negative activity. The MIC of neomycin-C16 (C20) conjugates against methicillin-resistant Staphylococcus aureus (MRSA) is comparable to clinically used antiseptics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778047     DOI: 10.1021/jm800345u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

Review 2.  Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold.

Authors:  Brandon Findlay; George G Zhanel; Frank Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

3.  Cholic Acid-Peptide Conjugates as Potent Antimicrobials against Interkingdom Polymicrobial Biofilms.

Authors:  Siddhi Gupta; Jyoti Thakur; Sanjay Pal; Ragini Gupta; Deepakkumar Mishra; Sandeep Kumar; Kavita Yadav; Amandeep Saini; Prabhu S Yavvari; Madhukar Vedantham; Archana Singh; Aasheesh Srivastava; Rajendra Prasad; Avinash Bajaj
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Inhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analogues.

Authors:  Janek Szychowski; Jiro Kondo; Omar Zahr; Karine Auclair; Eric Westhof; Stephen Hanessian; Jeffrey W Keillor
Journal:  ChemMedChem       Date:  2011-09-08       Impact factor: 3.466

5.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

6.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

7.  New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides.

Authors:  Guillaume Sautrey; Louis Zimmermann; Magali Deleu; Alicia Delbar; Luiza Souza Machado; Katy Jeannot; Françoise Van Bambeke; Julien M Buyck; Jean-Luc Decout; Marie-Paule Mingeot-Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 8.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

Review 9.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

10.  Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.

Authors:  Marina Y Fosso; Sanjib K Shrestha; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  J Med Chem       Date:  2015-12-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.